Please join our staff as we participate or present in the following oral and poster presentations at the 2018 ASCO Annual Meeting
2:45-3:05 p.m.
Hall D1
EDUCATION SESSION:
My Patient Was Diagnosed with Nontargetable
Advanced Non-Small Cell Lung Cancer: What Now?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Assessment and diagnostics of newly diagnosed
patients with advanced non-small cell lung cancer
Nathan Pennell, MD, PhD – Speaker
3:05-3:25 p.m.
S100bc
EDUCATION SESSION:
Personalizing Postoperative Treatment for Head
and Neck Cancer Nodal disease in HPV-positive and HPV-negative
cancer: Who needs postoperative radiation?
Shlomo Koyfman, MD – Speaker
3:25-3:45 p.m.
E253c
CLINICAL PROBLEMS IN ONCOLOGY SESSION:
When Less Is More: Local-Regional Management
of Breast Cancer Is abbreviated radiation a reality?
Chirag Shah, MD – Speaker
3:45-3:57 p.m.
S102
ORAL ABSTRACT SESSION:
ALLELE: A consortium for prospective genomics
and functional diagnostics to guide patient care
and trial analysis in newly-diagnosed glioblastoma
Abstract 2003
Manmeet Ahluwalia, MD – Author
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Gene editing technology offers promise for treating multiple myeloma and other hematologic malignancies, as well as solid tumors
Study of 401,576 patients reveals differences in cancer burdens as well as overall survival
Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy